Biotrin Intl to develop a nucleic acid test (NAT) analyser

DiaSorin has announced that its fully owned Irish subsidiary Biotrin International has signed an agreement with Precision System Science (PSS) of Japan for the development of a nucleic acid test (NAT) analyser.

PSS is a provider of laboratory instruments for nucleic acid extraction and amplification and has several years of experience in the development and production for third parties of automated instruments in the field of molecular diagnostic. According to this agreement, PSS will develop the first-generation analyser to be used in conjunction with a panel of nucleic acid tests in the clinical area of infectious disease which are in development at Biotrin using the LAMP technology.

Biotrin is the DiaSorin centre for the development and manufacture of molecular diagnostics products using the LAMP (loop mediated isothermal amplification) technology, licensed from Eiken Chemical Company. The first panel of applications will be in the field of infectious disease and onco-haematology and will complement DiaSorin’s current extensive Liaison product offering in the field of immunodiagnostics. The commercial launch is expected to happen in the second half of next year.